GlassScriptPhysician profile
Aldo Angelo Lombardo
NPI 1609807387
$9,253.17
in general payments reported to CMS, 2019-2025
10 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,529 · 2020: $112 · 2021: $230 · 2022: $168 · 2023: $289 · 2024: $754 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.45 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $7,820.02 | 2019-2022 | |
| Dilon Technologies, INC. | $541.66 | 2023-2024 | Hemoblast Bellows |
| Integra Lifesciences Corporation | $325.80 | 2024 | Durasorb Monofilament Mesh |
| Abbvie INC. | $151.89 | 2023-2025 | |
| Merz North America, INC. | $125.63 | 2020-2023 | Xeomin |
| Sientra, INC. | $118.44 | 2020-2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $73.02 | 2025 | |
| Mentor Worldwide LLC | $56.79 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $25.05 | 2021 | |
| Motiva USA, LLC | $14.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aldo Lombardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.